↓ Skip to main content

Dove Medical Press

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, December 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 2,600)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
89 X users
facebook
2 Facebook pages

Readers on

mendeley
140 Mendeley
Title
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes
Published in
International Journal of Chronic Obstructive Pulmonary Disease, December 2016
DOI 10.2147/copd.s117196
Pubmed ID
Authors

Sinthia Bosnic-Anticevich, Henry Chrystyn, Richard W Costello, Myrna B Dolovich, Monica J Fletcher, Federico Lavorini, Roberto Rodríguez-Roisin, Dermot Ryan, Simon Wan Yau Ming, David B Price

Abstract

Patients with COPD may be prescribed multiple inhalers as part of their treatment regimen, which require different inhalation techniques. Previous literature has shown that the effectiveness of inhaled treatment can be adversely affected by incorrect inhaler technique. Prescribing a range of device types could worsen this problem, leading to poorer outcomes in COPD patients, but the impact is not yet known. To compare clinical outcomes of COPD patients who use devices requiring similar inhalation technique with those who use devices with mixed techniques. A matched cohort design was used, with 2 years of data from the Optimum Patient Care Research Database. Matching variables were established from a baseline year of follow-up data, and two cohorts were formed: a "similar-devices cohort" and a "mixed-devices cohort". COPD-related events were recorded during an outcome year of follow-up. The primary outcome measure was an incidence rate ratio (IRR) comparing the rate of exacerbations between study cohorts. A secondary outcome compared average daily use of short-acting beta agonist (SABA). The final study sample contained 8,225 patients in each cohort (mean age 67 [SD, 10], 57% males, 37% current smokers). Patients in the similar-devices cohort had a lower rate of exacerbations compared with those in the mixed-devices cohort (adjusted IRR 0.82, 95% confidence interval [CI] 0.80-0.84) and were less likely to be in a higher-dose SABA group (adjusted proportional odds ratio 0.54, 95% CI 0.51-0.57). COPD patients who were prescribed one or more additional inhaler devices requiring similar inhalation techniques to their previous device(s) showed better outcomes than those who were prescribed devices requiring different techniques.

X Demographics

X Demographics

The data shown below were collected from the profiles of 89 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 139 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 16%
Other 16 11%
Researcher 16 11%
Student > Ph. D. Student 12 9%
Student > Bachelor 9 6%
Other 30 21%
Unknown 35 25%
Readers by discipline Count As %
Medicine and Dentistry 46 33%
Pharmacology, Toxicology and Pharmaceutical Science 22 16%
Nursing and Health Professions 14 10%
Agricultural and Biological Sciences 5 4%
Engineering 3 2%
Other 9 6%
Unknown 41 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2023.
All research outputs
#679,660
of 25,827,956 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#24
of 2,600 outputs
Outputs of similar age
#13,623
of 419,128 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#2
of 82 outputs
Altmetric has tracked 25,827,956 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 419,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.